"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (DIE-aze-OX-ide) |
| Hyperstat IV |
| Class: Agent for hypertensive emergencies |
Action Relaxes smooth muscle in peripheral arterioles, thus reducing blood pressure.
Indications Short-term emergency reduction of blood pressure in severe, nonmalignant and malignant hypertension in hospitalized patients.
Contraindications Dissecting aortic aneurysm; hypersensitivity to thiazides or other sulfonamide derivatives; treatment of compensatory hypertension, such as that associated with aortic coarctation or arteriovenous shunt. Diazoxide is ineffective against hypertension caused by pheochromocytoma.
ADULTS: IV 1–3 mg/kg (maximum 150 mg in single injection) by rapid injection. May repeat at 5–15 min intervals until satisfactory reduction in blood pressure. May repeat at intervals of 4–24 hr until oral therapy can be initiated. Do not use for more than 10 days.
Antihypertensive agents: Enhanced antihypertensive effect. Highly protein-bound agents: Higher blood levels of these agents may occur as a result of displacement by diazoxide. Hydantoins: Possible loss of seizure control. Sulfonylureas: Hyperglycemia may occur. Thiazide diuretics: May increase hyperuricemic, hyperglycemic and antihypertensive effects of diazoxide.
Lab Test Interferences Hyperglycemia and hyperuricemia produced by diazoxide may affect assessment of these metabolic states. Increased renin secretion and IgG concentrations and decreased cortisol secretion may occur. May cause false-negative insulin response to glucogon.
CV: Sodium and water retention; hypotension to shock levels; congestive heart failure; edema; myocardial ischemia (angina, arrhythmias, ECG changes); supraventricular tachycardia; palpitations; bradycardia. CNS: Dizziness; weakness; cerebral ischemia; cerebral infarction (unconsciousness, convulsions, paralysis, confusion, focal neurologic deficit); sweating; flushing and feelings of warmth; transient neurologic findings (eg, headache, lethargy, somnolence, euphoria, ringing in the ears, momentary hearing loss). DERM: Cellulitis or phlebitis at site of extravasation; warmth or pain along course of injected vein. GI: Nausea; vomiting; acute; pancreatitis; diarrhea; abdominal discomfort. META: Hyperglycemia; hyperosmolar coma; hyperuricemia. OTHER: Hypersensitivity reactions; papilledema.
Pregnancy: Category C. Lactation: Undetermined. Special risk patients: Diabetic patients may need treatment for hyperglycemia. Use with care in patients with impaired cerebral or cardiac circulation in whom rapid reduction in BP might be deleterious. Observe caution when reducing severely elevated BP. Fluid and electrolyte balance: Because of sodium and water retention, with possible edema and congestive heart failure, concomitant use of diuretic may be needed. However, thiazide diuretics may potentiate diazoxide’s antihypertensive, hyperglycemic and hyperuricemic actions.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 1% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply